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Abstract
The experimental infection of a mouse lung with influenza A virus has proven to be an invaluable model for studying the
mechanisms of viral adaptation and virulence. The mouse adaption of human influenza A virus can result in mutations in the
HA and other proteins, which is associated with increased virulence in mouse lungs. In this study, a mouse-adapted seasonal
H1N1 virus was obtained through serial lung-to-lung passages and had significantly increased virulence and pathogenicity
in mice. Genetic analysis indicated that the increased virulence of the mouse-adapted virus was attributed to incremental
acquisition of three mutations in the HA protein (T89I, N125T, and D221G). However, the mouse adaption of influenza A
virus did not change the specificity and affinity of receptor binding and the pH-dependent membrane fusion of HA, as well
as the in vitro replication in MDCK cells. Notably, infection with the mouse adapted virus induced severe lymphopenia and
modulated cytokine and chemokine responses in mice. Apparently, mouse adaption of human influenza A virus may
change the ability to replicate in mouse lungs, which induces strong immune responses and inflammation in mice.
Therefore, our findings may provide new insights into understanding the mechanisms underlying the mouse adaption and
pathogenicity of highly virulent influenza viruses.
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Introduction
Seasonal influenza A viruses can cause acute respiratory
infections with high morbidity and considerable mortality,
particularly in children and the elderly [1]. The disease is
characterized by a sudden onset of malaise and fever, followed
by upper and sometimes lower respiratory signs, myalgia, and
headache [2]. Systemic disease manifestations subside once the
virus is cleared, usually within three to five days after the infection,
but respiratory signs including coryza and cough may persist
longer [2]. Severe diseases and mortality occur preferentially in
immunocompromised patients and individuals with pre-existing
lung diseases, and are often due to secondary bacterial infections
[3]. However, the pathogenic process of influenza virus infection
and related immune responses are not fully understood.
The mouse model of influenza is an excellent model for studying
the pathogenesis of influenza virus because mice infected with
influenza can develop pneumonia, pathologically similar to that in
humans [4]. Experimental infection of mouse lungs with influenza
virus has provided insights into understanding viral pathogenicity
and adaption [5]. Notably, mice are naturally insusceptible and
insensitive to infection with influenza viruses and mice infected
with newly isolated human influenza A viruses usually become
asymptomatic. Many strains of mice can be infected experimen-
tally with influenza viruses, particularly with mouse lung-adapted
viruses [6], and allow the infected viruses to replicate in their lungs
[5]. Following infection with influenza A virus, the virus induced
humoral immunity can clear the viruses in the lungs around five
days post infection. However, mice infected with the mouse-
adapted influenza viruses can display pathogenic inflammation in
the bronchi and lungs, leading to alveolitis and lethal pneumonitis,
similar to that in humans [4,7]. Hence, the changes in the viruses
during mouse adaptation may provide new insights into
understanding factors contributing to the development of virus-
related lung inflammation in humans. Furthermore, adaption of
human influenza virus to mice by serial passages can result in
genetic variants with the mutations in multiple genes, such as
hemagglutinin (HA), which is a primary factor of mouse lung
virulence because of its receptor binding and host membrane
fusion activities [8,9,10,11,12,13], and other genes for M, PA,
PB1, PB1-F2, PB2, and NS1 [12,13,14,15,16,17,18,19,20,21,22,
23,24]. Previous studies have shown that mouse-adapted A/FM/
1/47(H1N1) (FM-MA) from 12 sequential mouse-lung passages
has a high ability to replicate and virulence [9], which is associated
with the mutations of Gly-to-Try at residue 47 of the HA2 subunit
and Thr-to-Ala at residue 139 of the matrix protein [13]. Further
studies indicate that the increased virulence to mice is controlled
by both mutations, whereas the enhanced replication in Madin-
Darby canine kidney (MDCK) cells is attributed to the mutation in
the matrix protein [13].
In the present study, the prototype seasonal H1N1, A/
Brisbane/59/2007, without a prior history of mouse passage,
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passages to identify the potential mutations associated with
virulence and viral infection-related inflammatory responses in
mice. We found that the mouse adaption not only directly affected
viral properties, but also indirectly modulated the host defense
system. Therefore, our findings may provide new insights into the
pathogenesis of infection with highly virulent strains of influenza
and related inflammation. We discussed the implications of our
findings.
Materials and Methods
Viruses and cells
The seasonal H1N1 influenza virus A/Brisbane/59/2007 (the
third passage in the allantoic cavities of 10-day-old chicken eggs)
was kindly provided by Dr. Honglin Chen (Hongkong University).
The virus was subsequently inoculated in the allantoic cavities of
10-day-old chicken eggs and cultured at 37uC for 48 h, and
aliquots were stored at 280uC. MDCK cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen,
Carlsbad, USA) supplemented with 10% FBS. All experiments
involving the mouse-adapted variants of the seasonal H1N1
influenza virus were conducted under biosafety level 3 (BSL-3)
conditions.
Adaption of seasonal H1N1 influenza viruses in mice
Mouse-adapted variants of A/Brisbane/59/2007 virus were
derived by eight sequential mouse lung-to-lung passages. Briefly,
female 5-week-old BALB/c mice were obtained from the Institute
of Laboratory Animal Sciences, Beijing, and housed in a specific
pathogen free facility. Individual mice were anesthetized with
tribromoethanol and inoculated intranasally with 50 ml of allantoic
fluid containing wild-type A/Brisbane/59/2007 virus. Three days
later, their lungs were collected, homogenized, and centrifuged.
Subsequently, 50 ml of the supernatants were used for the next
passage. After a total of 8 passages, the viruses in the lung
homogenates were further cloned once by plaque purification in
MDCK cells, and the cloned virus was passaged once in the
allantoic cavities of 10-day-old chicken eggs at 37uC for 48 h to
prepare a virus stock. The experimental protocol was evaluated
and approved by the Institute of Animal Use and Care Committee
of the Institute of Laboratory Animal Science, Peking Union
Medical College (ILAS-PC-2010-002).
Determination of viral infectivity
The infectivity of wild-type and mouse-adapted seasonal H1N1
viruses was determined in MDCK cells by plaque assay and
expressed as log10 plaque-forming units (PFU) per milliliter.
Briefly, confluent MDCK cells were inoculated with 10-fold serial
dilutions of virus at 37uC for 1 h. The cells were then washed and
cultured with minimal essential medium (MEM) containing
tosylsulfonyl phenylalanyl chloromethyl ketone (TPCK)-treated
trypsin (0.5 mg/ml) and antibiotics (Sigma, St Louis, USA) at 37uC
for 48 h, and the formed plaques were visualized by neutral red
staining.
DNA sequencing and alignment
All gene segments of each passage of the viruses in the
supernatants of homogenized lungs of mice were amplified by high
fidelity PCR (KOD plus DNA polymerase, Toyobo, Japan). The
PCR products were purified and cloned into a pGEM-T easy
vector (Promega, Madison, USA). A total of five positive clones for
each gene segment of individual types of viruses were selected
randomly for sequencing (Invitrogen, Shanghai, China). The
resulting sequences of all viruses were analyzed and aligned using
ClustalW software (version 1.83).
Replication kinetics in MDCK cells
To determine multistep growth curves of the virus in vitro,
MDCK cells in six-well plates were infected in duplicate with
25 PFU of wild-type and mouse-adapted viruses, respectively.
After 60 min absorption at 37uC, the cells were washed and
cultured with 3 ml of serum-free MEM containing TPCK-treated
trypsin (0.5 mg/ml) and antibiotics for 72 h. The cell supernatants
(100 ml) were collected at 0, 12, 24, 36, 48, 56, and 72 h post
infection and centrifuged at 30006 g for 10 min, followed by
titrating by PFU assay and storing at 280uC.
Pathogenicity of virus in BALB/c mice
To compare the pathogenicity of wild-type with mouse-adapted
viruses in vivo, female 5-week-old BALB/c mice (n=20 per group)
were anesthetized and inoculated intranasally with 50 ml
(10
4.2 PFU) of each type of virus, respectively. Ten mice were
selected randomly from each group for monitoring the signs of
disease, weight loss, and mortality daily up to 14 days post
inoculation (d.p.i.). The remaining ten mice in each group were
euthanized at 4 d.p.i. and their blood samples, bronchoalveolar
lavage fluid (BALF), and lung tissues were collected for subsequent
analysis of viral replication, lung histology, pro-inflammatory
cytokines, hemostatic parameters, and T lymphocytes counts.
Real-time PCR
Total RNA was isolated from individual BALF samples using
the RNeasy Mini Kit, according to the manufacturer’s instructions
(Qiagen, Hilden, Germany). The RNA was reversely transcribed
into cDNA using random primers and a SuperScript II reverse
transcriptase (200 U) reaction mixture (20 ml) (Invitrogen). The
target gene mRNA transcripts were determined by RT-PCR using
a SYBR Green PCR Master Mix, the specific primers, and a
StepOne PCR system (ABI, USA). The sequences of primers were
forward 59-ctgagaagcagatactgggc-39 and reverse 59-ctgcattgtctcc-
gaagaaat-39 for HA gene fragment (340 bp), using GAPDH gene
fragment amplification as the internal reference control. The PCR
amplifications were performed in duplicate at 94uC for 3 min, and
subjected to 35 cycles of 94uC for 30 s, 55uC for 30 s, and 72uC
for 30 s.
Pathological analysis
Immediately following euthanasia, the mouse lungs were
removed, inflated, and fixed with 10% neutral buffered formalin
overnight at 4uC. Subsequently, the formalin-preserved lung
samples were embedded in paraffin and sectioned. Serial lung
tissue sections at 4-mm were stained with Hematoxylin and Eosin
(H&E), and examined for pathological changes under a light
microscope (Olympus BX-50).
Receptor-binding assay
Synthetic 39-sialyl-N-acetyllactosamine (39SLN-PAA)-Biotin,
39SLN-DI-PAA-Biotin (double saccharide connection in series),
69-sialyl-N-acetyllactosamine (69SLN-PAA)-Biotin, and 69SLN-DI-
PAA-Biotin (double saccharide connection in series) were provided
by the Scripps Research Institute (La Jolla, CA, USA). The
receptor binding procedure was carried out as described
elsewhere, with some modifications [25]. Briefly, sialosaccharides
at 0–10 mg/ml were coated on 96-well flat-bottom polystyrene
plates and allowed to attach overnight at 4uC. The plates
containing sialylosaccharides were crosslinked under a UV light
Adaption of Seasonal H1N1 Influenza Virus in Mice
PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e28901at 254 nm for 10 min and after washed five times with PBS, the
plates were blocked with 2% skim dry milk in PBS for 8 h at 4uC.
After washed five times with 0.1% Tween-20 PBS, individual wells
in the plates were added in sextuplicate with virus culture
supernatants (50 ml) containing 32 HAU and incubated on ice
overnight, respectively. After washing, the bound viruses were
detected with a mouse monoclonal antibody against the A/
Brisbane/59/2007 strain (Sino Biological, Beijing, China) and
visualized by horseradish peroxidase (HRP)-conjugated anti-
mouse IgG antibodies and tetramethylbenzidine substrate solu-
tion, followed by measuring absorbance at 450 nm. A/Shenzhen/
406H/2006 (H5N1) and A/Brisbane/10/2007 (H3N2) viruses
were used as positive controls for 39SLN and 69SLN bindings,
respectively.
Hemolysis assay
Hemolysis assay was performed in 96 well round bottom
microtiter plates. Briefly, 25 ml of each type of virus (640 HAU)
was reacted in triplicate with 50 ml of the 2% pre-washed turkey
erythrocytes at 4uC for 10 min and centrifuged (10006 g for
2 min). After removing the supernatants, the virus and erythrocyte
mixture was cultured with 75 ml of 100 mM citrate buffers with
varying pH values from 4.8 to 6.0 in increments of 0.1 pH unit at
37uC for 1 h and centrifuged. Subsequently, their supernatants
were transferred to flat bottom ELISA plates for measuring at
540 nm [26]. The FM-MA (H1N1) virus was used as a positive
control to validate the hemolysis assay, as compared with the data
published previously (15, 31). Meanwhile, Escherichia coli was used
as a virus-free negative control.
Hematology analysis
The total white blood cell (WBC) counts and lymphocytes in
individual heparinized blood samples were determined on an ACT
TM laser-based hematology analyzer (Beckman Coulter, USA).
Flow cytometry analysis
Peripheral blood samples were collected from individual mice
and peripheral blood mononuclear cells were prepared. The cells
were treated with the purified anti-CD16/32 and stained with
FITC-anti-CD3, PE-anti-CD4, or APC-anti-CD8, respectively.
The frequency of different subsets of T cells was determined by
flow cytometry (FACS CANTO, BD, USA).
Quantification of cytokines and chemokines
The concentrations of granulocyte colony-stimulating factor (G-
CSF), granulocyte-macrophage colony-stimulating factor (GM-
CSF), interferon-c (IFN-c), monokine induced by IFN-c (MIG),
interleukin-1a (IL-1a), IL-1b, IL-4, IL-6, IL-10, IL-12/IL-23p40,
IL-13, IL-17, IL-21, monocyte chemoattractant protein 1 (MCP-
1), macrophage inflammatory protein 1a (MIP-1a), MIP-1b,
tumor necrosis factor (TNF), and keratinocyte-derived chemokine
(KC) in serum and BALF samples were determined by flow
cytometry (FACS CANTO, BD, USA) using the Cytometric
Beads Array (CBA) Kits, according to the manufacturers’
instructions (BD, USA). Briefly, 50 ml of each testing sample were
labeled in duplicate with equal volumes of diluted FlexSet capture
beads at room temperature for 1 h and treated with PE-
conjugated detection reagent. After washing, the captured
cytokines and chemokines were analyzed by flow cytometry.
Statistical analysis
Data are expressed as mean 6 SD. The difference among
different groups was analyzed by one-way ANOVA and post hoc.
Bonferroni correction analysis and the difference between two
groups were analyzed by Student’s t-test using SPSS 11.5 software.
A probability value of ,0.05 was considered as statistically
significant.
Results
Adaption of seasonal H1N1 virus in mice
Seasonal H1N1 influenza viruses are almost avirulent to mice.
To increase the virulence of H1N1 influenza virus, individual mice
were inoculated intranasally with 10
6.2 PFU A/Brisbane/59/2007
virus, and three days later, their lungs were dissected out and the
supernatants of lung homogenates were used for continual eight
passages to generate mouse-adapted variants. While inoculation
with wild-type (WT) and mouse-adapted A/Brisbane/59/2007
from passage 1 to 2 (MA-1 to MA-2) did not result in obvious
clinical symptoms and lung lesions in mice, the viral titers in the
lung tissues increased from 5.05 to 6.67 log10 PFU/g. The mice
inoculated with MA-3 to MA-5 developed clinical symptoms,
including hunched posture and ruffled fur, and displayed large
lesions in the lung tissues, accompanied by increasing viral titers to
7.19–7.59 log10 PFU/g. Some mice inoculated with MA-6 were
dead while all of the mice inoculated with MA-8 died or were in
agonal states, accompanied by defuse inflammation in the lungs
and increasing viral titers to 8.78-8.62 log10 PFU/g, indicating
high virulence and pathogenicity (Table 1 and Fig. 1).
Sequence analysis of mouse-adapted H1N1 viral
genomes
The full-length sequences of each passage of viruses in the
supernatants of homogenized lungs of mice were obtained by high
fidelity PCR and cloned. Subsequently, five positive clones were
selected randomly from individual libraries for sequencing.
Genomic mutations in those mouse-adapted viruses are listed in
Table 2. Identical sequences were detected from five clones of
each gene segment and the mutations of all virus isolates were
located in the HA coding sequence. While the MA-2, MA-3, and
MA-6 gradually obtained the HA mutations at position of 125
(Asn-to-Thr), 221 (Asp-to-Gly), and 89 (Thr-to-Ile), respectively,
there were no genomic substitutions between MA-6 and MA-8
viruses. Furthermore, there was no synonymous mutation detected
in any of the genome segments during the process of mouse lung
adaption. The sequences of the HA gene in wild-type and MA-2,
MA-3, MA-8 viruses were deposited in GenBank under accession
numbers of JN899402, JN899403, JN899404, and JN899405.
Growth characteristics of mouse-adapted H1N1 viruses in
MDCK cells
To evaluate the replication ability of the mouse-adapted
seasonal H1N1 A/Brisbane/59/2007 viruses, we assayed the viral
yields of three representative strains (MA-2, MA-3, and MA-8)
with a respective wild-type strain after multiple replication cycles
in MDCK cells. Analysis of replication kinetics showed that the
titer of wild-type virus was 10
2.54 PFU at 12 h.p.i, and then rose to
10
5.358 at 24 h.p.i and maintained in 10
5 until 72 h.p.i. The three
mouse adapted viruses showed the growth kinetics similar to that
of the wild-type virus, and there was no significant difference in the
viral titers and growth rates between wild-type and mouse-adapted
viruses (P.0.05, Fig. 2).
Pathogenicity of mouse-adapted H1N1 viruses in vivo
To compare the virulence and pathogenicity of the wild-type
with mouse-adapted seasonal H1N1 A/Brisbane/59/2007 viruses
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MA-3, and MA-8 viruses, respectively, and their mortality, mean
survival days, total weight loss, viral RNA loads in BALF, and viral
titers in lung tissues were evaluated. The percentages of mice that
survived during the observation period are shown in Figure 3A. All
of the mice infected with WT virus survived. In contrast, only 70%
of the mice inoculated with MA-2 and MA-3 viruses survived on
14 d.p.i, and the mean survival days [27] were 11.6 and 10.9,
respectively. However, all of the mice infected with MA-8 died on
7 d.p.i with a mean survival period of 3.9 days, accompanied by
32% body weight loss. The loss of body weight in the mice
inoculated with MA-2 and MA-3 viruses were less than 30% on
7 d.p.i, after which the mice began to steadily regain their body
weight over the remaining observation period. In contrast, the
body weight in the mice infected with WT virus continued to
increase throughout the observation period (Fig. 3B).
To further investigate the pathogenicity of the wild-type and
mouse-adapted seasonal H1N1 A/Brisbane/59/2007 viruses, we
determined the virus loads in BALF and lung tissues of mice at
4 d.p.i (Fig. 3C and D). Mice inoculated with MA-8 virus
presented with the highest numbers (3.02610
7 copies/ml) of virus
in BALF, which was significantly higher than that in the mice
infected with the other three viruses (P,0.05). However, the RNA
copy numbers in BALF of the mice infected with other two mouse-
adapted viruses (MA-2, MA-3) were significantly higher than that
in the mice infected with the wild-type virus (3.20610
5 copies/ml,
P,0.05). Similarly, mice infected with MA-8 exhibited the highest
titer (9.21 PFU/g) of virus in their lung tissues, which was
significantly higher than that with WT (5.46 PFU/g), MA-2
(7.17 PFU/g), and MA-3 (7.80 PFU/g) (P,0.05).
Characterization of inflammation in the lungs revealed that all
lung tissue samples exhibited characteristic pathology of influenza
infection, including inflammatory hyperaemia, hemorrhage,
edema, and exudative pathological changes. Mice harboring
MA-8 virus exhibited the most robust pathological lesions
occurring in 100% of the lung tissues (Fig. 4).
Effect of the mutations in the HA on receptor binding
ability and pH optimum fusion
Previous studies have suggested that HA mutations may
modulate the affinity of HA binding to host sialyl receptors to
increase virus virulence [28,29,30]. Accordingly, we examined the
binding abilities of WT, MA-2, MA-3, and MA-8 to synthetic
sialic substrates in vitro. As expected, there was no wild-type and
mouse-adapted seasonal H1N1 A/Brisbane/59/2007 viruses
binding to the avian-type of 39SLN or 39DI-SLN receptors
(Fig. 5A and B). Furthermore, there was no significant difference
in the bindings of virus to the human-type of 69SLN and 69DI-
SLN receptors among those four types of H1N1 viruses (Fig. 5C
and D). Two control viruses, A/Shenzhen/406H/2006 (H5N1)
and A/Brisbane/10/2007 (H3N2), selectively bound to 39 and 69
substrates, verifying the specificity and validity of the sialyl
receptor binding assay.
Next, we determined the optimum pH of fusion for WT, MA-2,
MA-3, and MA-8 using hemolysis as an indicator of fusion. The
results showed that there were no significant difference in the
fusion properties from pH 4.8 to 6.0 between WT and MA viruses
Table 1. Clinical characteristics of mice.
Virus Death Impending death Clinical symptoms of alive Pathological change of lung tissues
WT 0 0 None None
MA-1 0 0 None None
MA-2 0 0 2/3 hunched posture and ruffled fur None
MA-3 0 0 3/3 hunched posture and ruffled fur 1/3 appeared nidus near hilum of lung
MA-4 0 0 3/3 hunched posture, ruffled fur 3/3 large area of lungs appeared lesions
MA-5 0 0 3/3 hunched posture, ruffled fur 3/3 large area of lungs appeared lesions
MA-6 1 0 2/2 hunched posture, ruffled fur 2/2 large area of lungs appeared lesions
MA-7 1 1 2/2 hunched posture, ruffled fur 2/2 all area of lungs appeared lesions
MA-8 2 1 1/1 hunched posture, ruffled fur 1/1 all area of lung appeared lesions
Note: WT, wild-type; MA, mouse-adapted and the number represents the passage. Groups of mice (n=3 per group) were inoculated with each type of wild-type or
mouse-adapted virus and monitored for three days. Subsequently, the mouse lungs were collected and the supernatants of lung homogenates were used for serial
passages.
doi:10.1371/journal.pone.0028901.t001
Figure 1. Adaption process of each passage of mouse-adapted
seasonal H1N1 A/Brisbane/59/2007 viruses in mouse lungs.
BALB/c mice were infected with wild-type virus and three days later,
their lungs were dissected out to generate the first passage of mouse-
adapted virus (MA-1). Subsequently, the lung lysates were used for
infection of mice to generate MA-2, which was subjected serial mouse
lung passages (total of eight passages). The replication of each
passaged virus was determined as viral titers in the lungs. Data are
expressed as mean 6 SD of viral titers (log10 PFU/mg) in the lungs of
each group of mice (n=3 per group) from three separate experiments.
* P,0.05 vs. the values of wild type virus.
doi:10.1371/journal.pone.0028901.g001
Adaption of Seasonal H1N1 Influenza Virus in Mice
PLoS ONE | www.plosone.org 4 December 2011 | Volume 6 | Issue 12 | e28901(Fig. 5E). These data indicated that the mutations in the HA in
mouse-adapted seasonal H1N1 A/Brisbane/59/2007 viruses did
not significantly change the specificity and affinity of their binding
to the receptors and the abilities of the virus to promote host
membrane fusion in vitro. The hemolysis profile of FM-MA (H1N1)
virus was in accordance with the data published previously
[15,31], but Escherichia coli failed to fuse with the turkey
erythrocytes, which verified the validity of the hemolysis assay.
Analysis of peripheral white blood cells in the challenged
mice
It has been reported that infection with influenza viruses can
cause leukopenia [32,33]. To determine the extent to which
infection with wild-type and mouse-adapted viruses induced
leukopenia in mice, peripheral blood leukocytes in different
groups of mice were counted (Table 3). There was no significant
difference in the percentage of neutrophils among the different
groups of mice. However, in comparison with those in the mice
infected with wild-type virus, the total numbers of white blood cells
(WBCs) in the mouse-adapted viruses infected mice were reduced
significantly (P,0.05), particularly in the mice infected with MA-8
(P,0.01) at 4 d.p.i. Significantly reduced numbers of lymphocytes
and monocytes were also observed in the mice infected with
mouse-adapted viruses. Analysis of the frequency of CD4
+ and
CD8
+ T cells revealed significantly lower frequency of CD4
+ and
CD8
+ T cells in the mice infected with mouse adapted viruses at
d.p.i (Fig. 6). Therefore, infection with the mouse-adapted viruses,
particularly with MA-8, induced severe leukopenia in mice.
Infection with the mouse-adapted viruses modulates
cytokine and chemokine responses in mice
To further investigate if there was a correlation between severe
disease and inflammatory cytokine and chemokine production in
virus-challenged mice, the concentrations of cytokines and
chemokines in sera and BALF were tested at 4 d.p.i using
Cytometric Beads Array (Fig. 7). In comparison with that in the
wild-type virus infected mice, infection with the mouse-adapted
viruses, particularly with MA-8 (p,0.01), promoted significantly
higher levels of IL-6, MCP-1, and G-CSF, but dramatically
reduced levels of IFN-c in BALF (P,0.05). Furthermore, infection
with the mouse-adapted viruses, especially with MA-8 (p,0.01),
induced higher levels of IL-10, G-CSF and moderate levels of
MCP-1, but remarkably reduced levels of MIG in sera (P,0.05).
However, there was no detectable IL-4, IL-12/IL-23p40, IL-13,
IL-17, IL-21, GM-CSF, and KC in sera and BALF, and there was
no significant difference in the concentrations of IL-6 in sera, IL-
10 and MIG in BALF, IL-1a, IL-1b, TNF, MIP-1a, MIP-1b in
both sera and BALF among the different groups of mice (data not
shown).
Discussion
Adaption is thought to be the driving force in evolution, during
which organisms are selected in nature because of increased fitness
conferred by beneficial mutations. Although mice are not naturally
infected with seasonal H1N1 influenza viruses, many strains of
mice can be infected with human strains of influenza viruses,
which can be adapted to the mouse by serial lung passage [6]. In
our study, a virulent strain of mouse adapted virus with virulence
was produced following eight serial lung-to-lung passages in mice.
Mice infected with the mouse-adapted viruses exhibited more
Figure 2. The replication kinetics of wild-type and mouse-
adapted seasonal H1N1 A/Brisbane/59/2007 viruses in MDCK
cells. MDCK cells were infected in triplicate with 25 PFU of each virus,
respectively. The viral yields (log10 PFU/ml) were measured at 12, 24,
36, 48, 56, and 72 h.p.i. Data are expressed as mean 6 SD of viral titers
(log10 PFU/mg) of each group of cells from three separate experiments.
doi:10.1371/journal.pone.0028901.g002
Table 2. Sequence alignment of wild-type and mouse-adapted seasonal H1N1 A/Brisbane/59/2007 viruses of each passage.
Virus PB2 PB1 PA HA NP NA M2&M1 NEP&NS1
nt aa nt aa nt aa
317 89 425 125 713 221
WT - - - C Thr A Asn A Asp - - - -
MA-1 - - - C Thr A Asn A Asp - - - -
MA-2 - - - C Thr C Thr AA s p - - - -
MA-3 - - - C Thr C Thr G Gly -- - -
MA-4 - - - C Thr C Thr G Gly -- - -
MA-5 - - - C Thr C Thr G Gly -- - -
MA-6 - - - T Ile C Thr G Gly -- - -
MA-7 - - - T Ile C Thr G Gly -- - -
MA-8 - - - T Ile C Thr G Gly -- - -
Note: WT, wild-type; MA, mouse-adapted; nt, nucleotide; aa: amino acid.
doi:10.1371/journal.pone.0028901.t002
Adaption of Seasonal H1N1 Influenza Virus in Mice
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BALF, higher virus titers, and more severe pathological changes in
mouse lung tissues, compared with that in the mice infected with
the wild-type virus.
Analysis of the potential molecular mechanism underlying the
high virulence of the adapted viruses revealed that there were
three mutations incrementally acquired at passage 2 (T89I),
passage 3 (N125T), and passage 6 (D221G). The T89I mutation
exists in another mouse lung adapted virus from A/USSR/90/
77(H1N1), but not in natural strains of the human and animal
influenza viruses [5,10]. It is proposed that the Thr at residue 89 of
HA1 is a potential glycosylation site, and the loss of glycosylation
sites in HA protein represents a common theme during mouse
lung adaptation [5]. The alteration has the potentials to impact on
the specificity and affinity of receptor binding and the pH of HA
mediated membrane fusion, contributing to the high virulence of
adapted viruses [5]. However, it is still uncertain whether the
increased virulence is caused by the T89I substitution only or the
combinations of the three mutations. We are interested in further
investigating the role of each mutation on the A/Brisbane/59/
2007 backbone in the virulence of adapted viruses.
The HA of influenza virus binds to receptors possessing
terminal N-acetyl neuraminic acid, also termed sialic acid (SA),
linked to galactose through either a2-3 or a2-6 bonds (a2,3 SA or
a2,6 SA, respectively). Subsequently, HA can internalize within
endosomes, and mediate fusion and uncoating due to low-pH-
induced conformational changes [34]. The HA of different types
of influenza viruses preferentially binds to the linkages that are
abundant in their natural host; for example, avian strains of viruses
preferentially bind to a2,3 SA, but human strains to a2,6 SA [35].
The a2,3 and a2,6 SA receptors were expressed on the trachea,
lung, cerebellum, spleen, liver and kidney, while the a2,6 SA
receptors were expressed by epithelial cells of the cecum, rectum
and blood vessels in the heart of BALB/c mice [36,37]. However,
we found that both wild-type and mouse-adapted viruses did not
bind to the synthetic a2,3 SA receptors and there was no
significant difference in the affinities of these viruses binding to the
synthetic a2,6 SA receptors in in vitro receptor binding assay.
Figure 3. The pathogenicity of wild-type and mouse-adapted seasonal H1N1 A/Brisbane/59/2007 viruses in BALB/c mice. Groups of
mice were inoculated intranasally with each type of virus (n=20 per group; 50 mlo f1 0
4.2 PFU) and ten mice were randomly selected and monitored
daily for signs of disease and mortality up to 14 d.p.i. The remaining ten mice from each group were sacrificed on 4 d.p.i., and their lung tissue and
bronchoalveolar lavage fluid (BALF) samples were used for determining the viral RNA and titers as well as histological examination. (A) Survival
percentage of mice. (B) Body weight changes of infected mice. Data are expressed as mean % 6 SD of each group of mice relative to the value
(100%) before inoculation. (C) Viral RNA loads in BALF. Data are presented as mean 6 SD of viral loads per milliliter of each group of mice. (D) Viral
titers in lung tissues. Data are presented as mean 6 SD of log10 PFU/mg from each group of mice. * P,0.05 or ** P,0.01 vs. the values of wild type
virus.
doi:10.1371/journal.pone.0028901.g003
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routine histological process and the tissue sections were stained with H&E. Data show are representative images (magnification6100) of each group
of mice (n=10 per group). (A) The lung tissue section from PBS mock infected mice; (B) The lung tissue section from the mice infected with WT virus;
(C) The lung tissue section from the mice infected with MA-2 virus; (D) The lung tissue section from the mice infected with MA-3 virus; (E) The lung
tissue section from the mice infected with MA-8 virus.
doi:10.1371/journal.pone.0028901.g004
Figure 5. The mouse-adapted virus has receptor binding and pH-dependent fusion properties similar to the wild-type virus. The
specificity and affinity of receptor binding and the pH-dependent hemolysis of the mouse adapted and wild-type viruses were determined by in vitro
binding to the synthetic biotinylated sialylglycopolymers and pH dependent hemolysis, respectively. Data are expressed as mean 6 SD of OD values
or percentage of lysing cells by each type of virus. The receptor binding profiles of A/Shenzhen/406H/2006 (H5N1) and A/Brisbane/10/2007 (H3N2)
viruses, and the hemolysis profile of FM-MA (H1N1) virus and Escherichia coli are shown as controls. (A) Binding to the 39SLN. (B) Binding to the 39DI-
SLN. (C) Binding to the 69SLN. (D) Binding to the 69DI-SLN. (E) The percentage of lysing cells.
doi:10.1371/journal.pone.0028901.g005
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the mouse-adapted viruses might not be critical for the binding of
virus to the receptors. Furthermore, some studies have shown that
mouse-adapted variants of human H1N1 and H3N2 viruses have
altered pH of fusion [11,31]. However, our in vitro hemolysis assay
showed that mutations also did not change the host membrane
fusion pattern of viruses. Although most of the mouse-adapted
variants have elevated pH of fusion, the role of this property in
virulence is not clear. Interestingly, the MA-8 displayed high
virulence, but did not alter the pH of fusion, indicating that an
increased pH of fusion was not necessary for the high virulence of
mouse-adapted viruses. We are interested in further investigating
how the mutations could contribute to the high virulence of mouse
adapted viruses.
Characterization of virus replication indicated that there was no
significant difference in the viral replication in MDCK cells
between wild-type and mouse-adapted viruses. This observation
was not surprising because a previous study has shown that the
mutations in the matrix protein are responsible for increased
replication of the mouse adapted A/FM/1/47 (FM) in vitro [13]
and that the neuraminidase protein (NA) is responsible for the
replication of A/WSN/33(H0N1) in MDBK cells [38]. Indeed,
the mutations that affect viral virulence can be classified according
to host-dependent and independent abilities to increase growth as
well as changes in pathological properties [14]. Given that all the
mutations were located in the HA of the mouse-adapted virus,
these mutations might have little effect on modulating in vitro
replication of the mouse adapted virus in MDCK cells.
The mouse-adapted virus showed significantly increased
virulence and pathogenicity in mice. However, the receptor
binding, the pH of HA mediated membrane fusion, and the in vitro
replication in MDCK cells of mouse-adapted viruses were similar
to that of the wild-type virus. These data suggest that the increased
virulence and pathogenicity of mouse-adapted viruses may be
attributed to their high immunogenicity that induces strong
inflammation in the mice. Evidentially, infection with the mouse-
adapted viruses, particularly with MA-8, induced severe lympho-
penia in mice. These findings were similar to that in previous
observations in humans infected with avian H5N1 or with triple-
reassortant swine influenza [32,33]. Similarly, mice infected with
H5N1 and reconstructed 1918 H1N1 viruses developed severe
lymphopenia [39,40], which is likely associated with redistribution
of lymphocytes that migrate into the inflammatory sites.
Furthermore, hypercytokinemia can induce hemophagocytic
syndrome that can result in pancytopenia due to excessive pan-
phagocytosis [41,42]. However, the precise mechanisms underly-
ing the lymphopenia remain to be further investigated.
Secondly, we found that infection with the mouse-adapted
viruses, particularly with MA-8, promoted high levels of pro-
inflammatory cytokine and chemokine production in mice.
Indeed, high levels of pro-inflammatory cytokines in nasal fluids
and plasma are associated with severities of diseases in human
volunteers infected with influenza virus, and strong cytokine
responses, such as ‘‘cytokine storm’’ are commonly observed in
cases infected with highly pathogenic influenza viruses, including
recent H5N1 fatalities [43,44,45]. The high levels of pro-
inflammatory cytokines in the mice further indicated high
virulence and pathogenicity of the mouse-adapted virus. Interest-
ingly, we detected significantly higher levels of IL-6, G-CSF, and
MIP-1 in BALF and IL-10 in sera, but lower levels of IFN-c and
MIG in BALF and sera of the mice infected with mouse-adapted
virus, respectively.
High levels of IL-6 have been detected in ferrets infected with
high virulent H1N1 [46] and in some cases with severe clinical
symptoms [43,47]. IL-10 is a negative regulator of innate and
adaptive immunity, and high levels of serum IL-10 may act as a
Figure 6. The frequency of peripheral blood CD4
+ and CD8
+ T lymphocytes. Peripheral blood samples were obtained from individual mice
at 4 d.p.i and their PBMC were prepared. Subsequently, those PBMC were stained with fluorescent anti-CD4 or anti-CD8 and the frequency of CD4
+
and CD8
+ T cells were determined by flow cytometry analysis. Data are expressed as mean 6 SD of percentages of CD4
+ or CD8
+ T cells in each group
of mice (n=10 per group) from three separate experiments. * P,0.05 and ** P,0.01 vs. the values in the mice infected with wild type virus.
doi:10.1371/journal.pone.0028901.g006
Table 3. Impact of viral infection on the mouse lymphocyte
populations in whole blood.
Virus WBC
a %L Y
b %N E
b %M O
b
None 10.3 76.7 36.6 8.3
WT 9.4 64.9 34.2 9.5
MA-2 5.9* 58.3* 36.2 7.4*
MA-3 5.4* 54.4* 47.4 8.9*
MA-8 2.7** 40.4** 62.4 9.1**
Note: WT, wild-type; MA, mouse-adapted.
aNumber of white blood cells (WBC) in whole blood, expresses as thousands of
WBCs per microliter of whole blood.
bMean percentage of leukocytes that are lymphocytes (LY), neutrophils (NE), or
monocytes (MO) from 10 mice per group at 4 d.p.i.
*Statistical significance: * P,0.05 and ** P,0.01 compared to the values of wild
type virus.
doi:10.1371/journal.pone.0028901.t003
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High levels of MCP-1 in BALF may be responsible for recruiting
inflammatory infiltrates in the lungs and have been detected in
cases with H5N1 and 2009 pandemic H1N1 virus infection and in
sera of macaques infected with 1918 H1N1 virus [49,50,51]. High
level of G-CSF was found to be significantly overexpressed in sera
and BALF from mice in which H3N2 influenza virus infection is
followed by superinfection with S. pneumonia serotype 3,
suggesting that G-CSF is a major contributor to synergistic
exacerbation of disease leading to fatal infection [52]. However,
our data presented here are the first report about the upregulation
of G-CSF in mice with severe disease following simple infection
with virulent influenza virus. Furthermore, studies based on ferrets
showed that influenza virus strains causing severe disease were
characterized by a lesser induction of type I and II interferons
[46], and monokines induced by IFN-c (MIG) have been shown to
exhibit direct antiviral properties [53] and to be essential in the
development of a protective Th1 response against viral infection in
the central nervous system [54]. Thus, the down-regulations of
IFN-c and MIG may be critical factors for inducing severe
pathogenicity in host animals or patients by some virulent
influenza viruses. These data suggest that altered levels of IL-6,
IL-10, G-CSF, MCP-1, IFN-c, and MIG may be indicators of the
progression to more severe disease caused by influenza viruses.
Apparently, mouse-adapted viruses clearly elicit a much greater
immune response than the wild-type virus, which may be mainly
caused by the mutations in the HA protein, and change the ability
to replicate in mouse lungs. However, whether the mutations have
increased the intrinsic immunogenicity of the virus is still under
investigation. Characterization of immune response of mice
Figure 7. The cytokine and chemokine responses. The concentrations of cytokines and chemokines in BALF and sera of individual mice were
measured quantitatively using Cytometric Beads Array. Data are expressed as mean 6 SD of the concentrations of individual cytokines or chemokines
in BALF or sera of each group of mice (n=10 per group) from three separate experiments. There was no significant difference in the concentrations of
other cytokines and chemokines tested (data no shown). * P,0.05 and ** P,0.01 vs. the values in the mice infected with wild type virus.
doi:10.1371/journal.pone.0028901.g007
Adaption of Seasonal H1N1 Influenza Virus in Mice
PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e28901against virus like particles (VLP) or recombinant protein would be
valuable to determine the immunogenicity of wild-type and
mutated HA proteins.
In conclusion, we obtained a lethal mouse-adapted seasonal
H1N1 virus following serial lung-to-lung passages of wild-type
virus in mice, and found that the mouse-adapted viruses had
mutations in the HA protein. Furthermore, the mouse-adapted
viruses had properties of receptor binding, the pH of HA mediated
membrane fusion, and the in vitro replication in MDCK cells,
similar to that of wild-type viruses, but it also had high virulence
and pathogenicity in mice. Evidentially, infection with the mouse-
adapted virus induced severe lymphopenia and strong pro-
inflammatory cytokine responses in mice. Apparently, mouse
adaption of the virus may change the ability of virus to replicate in
mouse lungs, which induces strong immune responses and
inflammation in mice. Therefore, our findings may provide new
insights into understanding the mechanisms of mouse adaption
and cross-species transmission of the human H1N1 viruses as well
as the pathogenesis of highly virulent influenza in humans.
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